AVTX
Avalo Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.07
−2.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.85x
- Price / sales
- 6426.51x
- Price / cash flow
- -5.71x
Enterprise value
- Enterprise value
- -$20.9M
- EV / sales
- -353.73x
- EV / EBITDA
- 0.21x
- EV / EBIT
- 0.23x
- Market cap
- $379.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026